PTPRC and acute myeloid leukemia: Additional experimental findings demonstrated that Integrin α L knockdown markedly suppressed AML cell proliferation and induced apoptosis, while concurrently reducing the number of CD45+ cells, decreasing spleen weight, and extending the survival duration of mice in the AML mouse model.